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INTRODUCTION
epatitis B virus (HBV) is one of the major causes
of acute and chronic hepatitis in the world.(1) It
is considered to be the most versatile of all
hepatotropic viruses, often producing acute infections with
or without jaundice, chronic hepatitis possibly progressing
to cirrhosis of the liver, or even a state of asymptomatic
Context: HBV infection is endemic in Brazil and acute HBV infection is still a common disease. Objective: To analyze incidence, risk
factors and evolution of acute HBV infection. Setting: University Hospital. Patients: 357 patients with acute HBV infection, comparing
two periods: 1985-1989 vs. 1990-1994. Results: The overall incidence declined from 50 new cases/year in 1985-89 (30% of all cases)
to 25 new cases/year in 1990-94 (8% of all cases). Transmission among male homosexuals (3.9% of cases in 85-89) declined to 1.3%
in 90-94 (p>0.05).  Amongst health care workers (HCW) it declined from 8.2% to 2.0% (p=0.02). Conversely, heterosexual transmission
increased from 4.8% to 10.1% (p=0.06). Chronification of HBV infection following the acute episode was observed in 1.7%. Fulminant
hepatic failure was seen in 3.4%. However, 27.2% of patients were lost to follow-up before normalization of the biochemical tests.
Conclusions: The different patterns of risk factors observed is probably related to measures for preventing AIDS and to HCW
vaccination programs. Chronification following acute episodes was not a common event.
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carrying of the infection. In addition, HBV may cause
fulminating hepatitis and plays an important role in the
genesis of hepatocellular carcinoma in the chronic forms
of the infection.(2)
The natural course of hepatitis B can be documented
by the determination of serologic markers of the infection
whose profiles are characteristic for acute, chronic or
fulminating infection.(3)
The control of HBV infection is currently possible
with the use of highly safe and effective vaccines against
hepatitis B.(4) However, most infections occur among adults
belonging to risk groups such as intravenous drug users
and male homosexuals, who are difficult to approach for
participation in vaccination programs.(5) Furthermore, the
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changing epidemiology of HBV infections complicates
even more the problem of the elaboration of adequate
programs for the prophylaxis of this disease.
In view of the above considerations, when adequate
programs for the control of HBV infection are elaborated,
it is important to be aware of the epidemiologic profile of
the infection in the different populations to be approached.
Thus, the objective of the present study was to investigate
the incidence of acute HBV hepatitis in patients who
sought a public health care service in a university hospital
in the city of São Paulo and to determine the routes of
transmission and forms of evolution of the disease, as well
as possible changes in the epidemiologic pattern over a
period of 10 years.
METHODS
Study population
A retrospective study was conducted on all the
patients who sought the Hepatitis Outpatient Clinic of the
Discipline of Gastroenterology, Escola Paulista de
Medicina, from January 1985 to December 1994 and who
were diagnosed as having HBV-induced acute hepatitis.
This diagnosis was based on clinical history and
biochemical evaluation and was confirmed by HBsAg and
anti-HBc IgM antibody positivity.
Following these criteria, patients with a diagnosis of
acute hepatitis B were classified by sex, age, year of onset
of the acute disease, possible route of transmission and
form of evolution of the disease.
For the characterization of evolutive patterns the
patients were classified into one of the following categories
after a follow-up of at least six months: 1. biochemical
normalization (ALT and AST), HBsAg negativity and
appearance of anti-HBs antibodies; 2. negativity of HBsAg
but without the appearance of anti-HBs antibodies; 3.
biochemical normalization and abandonment of follow-
up before serologic reevaluation; 4. abandonment of
follow-up before biochemical normalization; 5. evolution
to chronic disease (persistence of HBsAg for more than 6
months); 6. fulminating course.
Procedures
All the charts from included patients were analyzed
in relation to demographic data, route of transmission
(transfusion, intrafamily contact, heterosexual contact,
health professionals, intravenous drug use, homosexuality,
tattoos or undetermined).
ALT and AST levels were determined by an
automated kinetic method using reagents from Roche
(normal ALT up to 41 UI/L and normal AST up to 38
UI/L).
The presence of serologic markers (HBsAg, anti-HBc
IgM and anti-HBs) was determined by an immu-
noenzymatic technique using Abbot kits (AUSZYME,
CORZYME and AUSAB).
Statistical analysis
Data were analyzed statistically by the chi-square test,
Fisher’s exact  test and the Student t-test, with the level of
significance set at 0.05.
RESULTS
A total of 2702 patients with various forms of acute
and chronic hepatitis were seen at the Hepatitis
Outpatient Clinic of Escola Paulista de Medicina from
January 1985 to December 1994. Of these, 357 (13%)
fulfilled the diagnostic criteria of acute hepatitis B; 200
(56%) were males and 157 (44%) females, ranging in
age from 14 to 78 years (mean age: 32 years; median:
42.5 years). Most patients (67%) were in the 20 to 40
year age range (Figure 1).
Most cases of acute HBV hepatitis were concentrated
in the 1985-1990 period, corresponding to 30% of the total
number of cases seen in the sector. A progressive and
significant decline in the contribution of acute hepatitis B
to the total number of cases seen was observed thereafter,
with a rate of only 8% of all cases from 1991 to 1994.
Figure 2 shows the occurrence of hepatitis B over the years
and the total number of patients seen annually at the
service.
The possible routes of transmission were: transfusion
(8.7%), intrafamily (7.8%), heterosexual (7.0%), health
professional (5.6%), intravenous drugs (5.3%), homo-
sexual (2.8%), and tattoos (1.2%). The possible route of
transmission could not be determined in 61.6% of cases.
When the two major study periods were compared
(1985-1989 vs 1990-1994), transmission by the hetero-
sexual route was found to have increased from 4.8% to
10.1% of cases (p=0.06), whereas the homosexual route
decreased from 3.9% to 1.3% (p>0.05). Similarly,
transmission among health professionals decreased
significantly from 8.2% to 2.0% (p=0.02), whereas cases
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of unknown transmission increased from 54.8% to 71.1%
(p<0.005) (Figure 3).
The rate of chronicity of the disease was 1.7% and a
fulminating course occurred in 3.4% of cases. Of the 357
patients studied, 123 complied with the recommended full
follow-up, including serologic evaluation after the cure.
Of these, 14% (16/123) did not show positivity for anti-
HBs antibodies despite having become negative for
HBsAg.
DISCUSSION
The prevalence of HBV infection in Brazil is
intermediate, with a rate of chronic carriers of the virus
ranging from 0.5% to 5%.(6) However, the country has
regions of high prevalence, with more than a 10% rate of
chronic carriers in certain populations studied in the
Western Amazon region.(7)
HBV is mainly transmitted by percutaneous or
mucosal membrane exposure to infectious body fluids.(8)
Although the HBV surface antigen (HBsAg) can be
demonstrated in a wide variety of body fluids, only blood
and semen are potentially infectious. Percutaneous
exposures resulting in HBV transmission include
transfusion of blood or blood derivatives, shared use of
needles and syringes for intravenous drug injection,
hemodialysis, acupuncture, and professional contact with
infected patients.(9)
Sexual and perinatal transmission of hepatitis B, in
turn, occurs by contact of mucosal membranes with
infectious blood or body fluids.(10)
The fact that effective measures are currently
available for the control of HBV infection justifies a careful
analysis of the trends shown by the routes of transmission
and the evolution of the disease over the last few years.
The present demographic data showing a discrete
predominance of men and a higher incidence in the 20 to
40 year age range agree with the literature. Most studies
have shown a sex ratio of 1.3:1 to 2:1.(11,12) In most studies,
the peak of incidence of the disease occurs among
adolescents and young adults, suggesting an important role
for the sexual route in the transmission of infection.(12)
As for the transmission routes, in most cases we could
not identify a risk factor, although the sexual route cannot
be ruled out under these circumstances. We only classified
as possible cases of heterosexual transmission those in
which the partner was known to be a carrier of the disease
or those that reported two or more sex partners over the
preceding six months.
The present study revealed that the incidence of acute
hepatitis B has progressively declined over the last few
years. The possible explanations for this fact could be,
first, the onset of AIDS with the consequent dissemination
of measures for the control and prevention of the disease
at a population-wide level. These measures, aimed at the
avoidance of parenteral and sexual transmission of AIDS,
Figure 1. Distribuition of patients with acute hepatitis B, according
to the age.
Figure 2. Occurence of acute hepatitis B over the years at a
University Hospital in São Paulo, Brazil.
Figure 3. Transmission routes for acute hepatitis B: comparison
between two periods of five years.
Routes of transmission *p<0.05
HCW: health care Workers: heterosexual transmission
Homos: homosexual transmission
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have resulted in reducing the incidence of hepatitis B, since
the two diseases share similar routes of transmission and
risk groups.
Studies conducted in other countries have reported
similar findings, with a sharp change in the epidemiologic
profile of the infection over the last few years.(13)
In addition, the application of effective vaccines
against hepatitis B to specific risk groups, especially health
professionals, has contributed to the overall reduction in
the number of cases.(14)
These observations are even more evident when we
compare the two study periods (1985-1989 vs. 1990-1994),
with a sharp decrease in the number of infections among
health professionals, a fact that, in our service, can
definitely be attributed to the vaccination campaigns
carried out within the São Paulo Hospital and Escola
Paulista de Medicina, starting in 1988. A comparison of
the two periods also showed a reduced incidence of cases
among male homosexuals, a fact that may be attributed to
measures for the prevention of AIDS.
Similar data were observed in the U.S., where HBV
infection predominated among male homosexuals during
the period from 1982 to 1985, followed by heterosexually
infected individuals and intravenous drug users, in that
order. From 1986 to 1988 this pattern changed, with a
predominance of the disease among drug users and a
predominance of heterosexual over homosexual trans-
mission. Cases of hepatitis B among health professionals
also declined during the same period as a consequence of
the vaccination campaigns.(15) The patients who do not
present identifiable risk factors represent a serious public
health problem since they are usually excluded from
immunization programs which, for cost reasons, have long
been limited to groups at risk of contracting the infection.
This problem, allied to the fact that the risk of chronicity
is much higher among children, justifies the tendency to
immunize all children during the first year of life in all
First World countries.
Regarding evolutionary aspects, in our series there
was a high percentage (3.4%) of cases with a fulminating
course. Data in the literature suggest that approximately
1% of all cases of hepatitis B follow a fulminating course.
We attribute this higher percentage to the fact that our
service is a reference center to which more severe cases
or patients with other complications associated with acute
hepatitis B are referred.
Few data are available in the literature about the
characteristics of the host or of the viral agent that might
be related to different forms of evolution of the disease. In
the case of fulminating evolution, genomic variations of
HBV, together with different degrees of host immune
response, seem to be an important determinant.(16)
Although a large number of patients abandoned
follow-up, a fact that impairs the evolutionary analysis of
the disease, we observed that chronicity after an episode
of acute hepatitis was infrequent (1.7%), confirming data
reported by others.(17,18) In a recent metanalysis study(19)
involving 10 papers published on the subject, the risk of
chronicity after HBV infection was >10% in 2 studies,
5% in 1 and <5% in the remaining 7 (being less than 1%
in 5 of them). In 3 of these studies the population consisted
of patients with acute jaundiced hepatitis whose rate of
chronicity was 2%. The factors related to the tendency to
chronicity usually involve host properties, i.e. genetic,
hormonal and nutritional characteristics, although factors
linked to the virus such as route of infection and viral load
also seem to play an important role.
Post-infection serologic follow-up was possible only
for 123/357 patients even though all patients were
instructed to return to the service after the sixth month of
disease, reflecting the low level of compliance of this
population, probably due to its precarious socioeconomic
level. Fourteen percent of the patients did not show
positivity for anti-HBs antibodies although they had
become negative for HBsAg. It should be pointed out that
all of these 16 patients were retested for anti-HBs antibody
3 months later and all were found to be still negative. Thus,
they started to present a serologic profile with anti-HBc
antibody alone. The presence of isolated anti-HBc
antibodies has also been observed in approximately 15%
of all blood donors and the present study confirms that
many of these donors may have had acute HBV infection
and did not show positivity for anti-HBs antibodies, despite
the negativity for HBsAg.(20) Further studies are needed to
determine all the elements that influence the development
of the different evolutionary forms of HBV infection,
whose epidemiologic characteristics and natural history
should be investigated whenever possible.
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RESUMO
Contexto: A infecção pelo vírus B é endêmica no Brasil e a infecção aguda pelo HBV ainda é freqüente. Objetivo: Analisar a
incidência, fatores de risco e formas evolutivas da hepatite aguda B. Local: Hospital universitário. Participantes: 357 pacientes
com hepatite B aguda, comparando dois períodos distintos: 1985-1989 vs. 1990-1994. Resultados: A incidência caiu de 50
casos novos/ano em 85-89 (30% de todos os casos atendidos), para 25 casos novos/ano (8% dos casos). A transmissão entre
homossexuais caiu de 3,9% dos casos em 85-89 para 1,3% em 90-94 (p>0.05). Entre profissionais de saúde, caiu de 8,2%
para 2,0% (p=0,02); Inversamente, a transmissão heterossexual aumentou de 4,8% para 10,0% (p=0,06). Cronificação seguindo
um episódio agudo de hepatite B ocorreu em 1,7% dos casos. Hepatite fulminante ocorreu em 3,4% dos casos; entretanto,
27,2% dos pacientes abandonaram o seguimento antes da normalização da ALT. Conclusões: A mudança do padrão
epidemiológico se deveu, possivelmente, às medidas de proteção adotadas contra a AIDS e à vacinação de profissionais de
saúde. A ocorrência de cronificação após o episódio agudo foi pouco freqüente.
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